MedPath

Ferric sulfate

Generic Name
Ferric sulfate
Drug Type
Small Molecule
Chemical Formula
Fe2H10O17S3
CAS Number
10028-22-5
Unique Ingredient Identifier
3HWS7HF5XD
Background

Ferric sulfate has the molecular formula of Fe2SO4, and it is a dark brown or yellow chemical agent with acidic properties. It is produced by the reaction of sulfuric acid and an oxidizing agent. It is used in different fields such as dermatology, dentistry and it is thought to present hemostatic properties by interacting chemically with blood proteins. By the FDA, ferric sulfate is a direct food substance affirmed in the GRAS category (Generally Recognized As Safe).

Indication

Ferric sulfate was first used in dermatology as part of the Monsel's solution. This solution is an antihemorrhagic agent used in skin and mucosal biopsies. The use of ferric sulfate in dermatology is under review as ferric sulfate is corrosive and injurious and it can cause degenerative changes that are not observed with other alternatives like collagen.

Ferric sulfate is also used as a coagulative and hemostatic agent. It is a mechanic hemostatic agent used directly on the damaged tissue.

In dentistry, ferric sulfate is used as a pulpotomy medicament to control pulpal bleeding, as an antibacterial agent and as a hemostatic reagent for restorative dentistry, for postextraction hemorrhage and for periradicular and endodontic surgery.

Neuroimaging Ancillary Study

Completed
Conditions
Iron Deficiency Anemia
Iron Deficiency Anemia of Pregnancy
Child Development
Neurodevelopmental Disorder of Foetus
Iron Deficiency Anemia Treatment
Fetal Neurodevelopmental Disorder
Interventions
First Posted Date
2022-09-19
Last Posted Date
2025-04-16
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
184
Registration Number
NCT05545527
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Jawaharlal Nehru Medical College, Belgaum, Karnataka, India

RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study

Active, not recruiting
Conditions
Iron Deficiency Anemia
Neurodevelopmental Abnormality
Autism Spectrum Disorder
Interventions
First Posted Date
2022-08-17
Last Posted Date
2023-11-29
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
538
Registration Number
NCT05504863
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Jawaharlal Nehru Medical College, Belgaum, Karnataka, India

๐Ÿ‡ฎ๐Ÿ‡ณ

S. Nijalingappa Medical College, Bagalkot, Karnataka, India

๐Ÿ‡ฎ๐Ÿ‡ณ

Raichur Institute of Medical Sciences, Raichur, Karnataka, India

Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial

Phase 4
Completed
Conditions
Infant, Low Birth Weight
Anemia of Pregnancy
Iron Deficiency Anemia
Interventions
First Posted Date
2022-05-03
Last Posted Date
2024-05-24
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
4368
Registration Number
NCT05358509
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Sawai Man Singh Medical College, Jaipur, Rajasthan, India

๐Ÿ‡ฎ๐Ÿ‡ณ

Jawaharlal Nehru Medical College, Belgaum, Karnataka, India

๐Ÿ‡ฎ๐Ÿ‡ณ

Raichur Institute of Medical Sciences, Raichur, Karnataka, India

and more 1 locations

Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies

Not Applicable
Terminated
Conditions
Primary Teeth
Pulpotomy
Interventions
First Posted Date
2016-05-26
Last Posted Date
2021-06-11
Lead Sponsor
Loma Linda University
Target Recruit Count
57
Registration Number
NCT02783911
ยฉ Copyright 2025. All Rights Reserved by MedPath